Caribou Biosciences (CRBU) Prepaid Assets (2020 - 2026)
Caribou Biosciences (CRBU) posted quarterly Prepaid Assets of $2.4 million for Q1 2026, down 60.9% year-over-year from $6.1 million in Q1 2025, and down 17.89% quarter-over-quarter from $2.9 million in Q4 2025.
Caribou Biosciences (CRBU) Prepaid Assets (2020 - 2026) Analysis & Trends
Caribou Biosciences (CRBU) has reported Prepaid Assets for 7 consecutive years, with $2.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets fell 60.9% year-over-year to $2.4 million; the TTM figure through Mar 2026 stood at $2.4 million (down 60.9% YoY), while the FY2025 annual figure was $2.9 million, down 55.79% from the prior year.
- Prepaid Assets fell to $2.4 million in Q1 2026 per CRBU's latest filing, from $2.9 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $8.6 million in Q3 2022 and bottomed at $1.4 million in Q2 2022.
- Historically, Prepaid Assets has averaged $5.5 million across 5 years, with a median of $6.1 million in 2025.
- Annual changes were most pronounced in 2023 — Prepaid Assets jumped 311.17% — and 2026, when it plunged 60.9%.
- Caribou Biosciences' Prepaid Assets stood at $7.9 million in 2022, then fell by 22.3% to $6.2 million in 2023, then climbed by 7.05% to $6.6 million in 2024, then tumbled by 55.79% to $2.9 million in 2025, then fell by 17.89% to $2.4 million in 2026.
- Business Quant data shows CRBU's Prepaid Assets at $2.4 million in Q1 2026, $2.9 million in Q4 2025, and $5.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Caribou Biosciences | 166.63 Mn | 54.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.34 Mn |
| Mar 31, 2026 | 2.39 Mn |
| Dec 31, 2025 | 2.91 Mn |
| Sep 30, 2025 | 5.32 Mn |
| Jun 30, 2025 | 5.78 Mn |
| Mar 31, 2025 | 6.12 Mn |
| Dec 31, 2024 | 6.59 Mn |
| Sep 30, 2024 | 6.58 Mn |
| Jun 30, 2024 | 6.32 Mn |
| Mar 31, 2024 | 6.91 Mn |
| Dec 31, 2023 | 6.16 Mn |
| Sep 30, 2023 | 7.07 Mn |
| Jun 30, 2023 | 5.56 Mn |
| Mar 31, 2023 | 6.11 Mn |
| Dec 31, 2022 | 7.92 Mn |
| Sep 30, 2022 | 8.56 Mn |
| Jun 30, 2022 | 1.41 Mn |
| Mar 31, 2022 | 1.49 Mn |
| Dec 31, 2021 | 7.24 Mn |
| Sep 30, 2021 | 5.95 Mn |